• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者神经精神症状发生发展的相关因素:一项系统综述

Factors Contributing to the Development of Neuropsychiatric Manifestations in Persons With Multiple Sclerosis: A Systematic Review.

作者信息

Sangster Elizabeth, Lanka Nidhi, Acharya Prakash, Virani Shikha, Afreen Sumayya, Perthiani Arvin, Nassar Sondos T

机构信息

Psychiatry and Behavioral Sciences, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

School of Medicine, St. George's University, St. George's, GRD.

出版信息

Cureus. 2024 Aug 8;16(8):e66432. doi: 10.7759/cureus.66432. eCollection 2024 Aug.

DOI:10.7759/cureus.66432
PMID:39246867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380372/
Abstract

Multiple sclerosis (MS) is the most common chronic demyelinating disease affecting the central nervous system (CNS) and is distinguished by neuroinflammation and neurodegeneration. It has four categories based on clinical course, with relapsing-remitting being the most common type. MS predominantly manifests with motor and sensory dysfunctions. However, neuropsychiatric manifestations such as depression, anxiety, schizophrenia, and bipolar disorder are not uncommon. Various factors may contribute to the development of these manifestations; therefore, this study aimed to unravel them. This systematic review implemented the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Five databases (PubMed, PubMed Central (PMC), ScienceDirect, Cochrane Library, and Google Scholar) were used to acquire articles published in the past five years. After screening and quality appraisal were completed, eight articles were deemed eligible for inclusion in this study. The study designs included cohort, cross-sectional, randomized-controlled trial (RCT), case report, case-control, and narrative review. The development of neuropsychiatric manifestations in persons with MS is influenced by various factors. These were categorized into morphological changes of the brain, immunological mechanisms, socioeconomic factors, and individual factors for discussion. Each factor was found to intermingle with the others, requiring further research to understand the features that each factor contributes. This is crucial for improving the quality of life (QOL) and prognosis for persons living with MS.

摘要

多发性硬化症(MS)是影响中枢神经系统(CNS)的最常见慢性脱髓鞘疾病,其特征为神经炎症和神经退行性变。根据临床病程可分为四类,复发缓解型是最常见的类型。MS主要表现为运动和感觉功能障碍。然而,抑郁、焦虑、精神分裂症和双相情感障碍等神经精神表现并不少见。多种因素可能导致这些表现的发生;因此,本研究旨在揭示这些因素。本系统评价遵循了系统评价和Meta分析的首选报告项目(PRISMA)2020指南。使用五个数据库(PubMed、PubMed Central(PMC)、ScienceDirect、Cochrane图书馆和谷歌学术)获取过去五年发表的文章。在完成筛选和质量评估后,八篇文章被认为符合纳入本研究的条件。研究设计包括队列研究、横断面研究、随机对照试验(RCT)、病例报告、病例对照研究和叙述性综述。MS患者神经精神表现的发生受多种因素影响。这些因素分为脑形态学改变、免疫机制、社会经济因素和个体因素进行讨论。发现每个因素都相互交织,需要进一步研究以了解每个因素所起的作用。这对于提高MS患者的生活质量(QOL)和预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/0920c825ebb2/cureus-0016-00000066432-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/f15eda415151/cureus-0016-00000066432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/11dd3b274d63/cureus-0016-00000066432-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/0920c825ebb2/cureus-0016-00000066432-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/f15eda415151/cureus-0016-00000066432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/11dd3b274d63/cureus-0016-00000066432-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c809/11380372/0920c825ebb2/cureus-0016-00000066432-i03.jpg

相似文献

1
Factors Contributing to the Development of Neuropsychiatric Manifestations in Persons With Multiple Sclerosis: A Systematic Review.多发性硬化症患者神经精神症状发生发展的相关因素:一项系统综述
Cureus. 2024 Aug 8;16(8):e66432. doi: 10.7759/cureus.66432. eCollection 2024 Aug.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
5
Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.伴有复发缓解型多发性硬化的轻度残疾患者的生活伴侣的照料者负担。
Mult Scler Relat Disord. 2019 Jun;31:5-11. doi: 10.1016/j.msard.2019.03.005. Epub 2019 Mar 6.
6
Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment.多发性硬化症患者抑郁的系统评价及其与干扰素β治疗的关系。
Mult Scler Relat Disord. 2017 Oct;17:138-143. doi: 10.1016/j.msard.2017.07.008. Epub 2017 Jul 12.
7
8
Depression and anxiety in multiple sclerosis. Review of a fatal combination.多发性硬化症中的抑郁和焦虑。致命组合的综述。
J Neural Transm (Vienna). 2024 Aug;131(8):847-869. doi: 10.1007/s00702-024-02792-0. Epub 2024 Jun 13.
9
Pharmacological treatment for memory disorder in multiple sclerosis.多发性硬化症记忆障碍的药物治疗。
Cochrane Database Syst Rev. 2013 Dec 17;2013(12):CD008876. doi: 10.1002/14651858.CD008876.pub3.
10
Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.血清脂质与多发性硬化症的认知结果:系统评价和荟萃分析。
Mult Scler Relat Disord. 2024 May;85:105530. doi: 10.1016/j.msard.2024.105530. Epub 2024 Feb 29.

本文引用的文献

1
Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis.绘制多发性硬化症患者脑白质病变与抑郁的关系图。
Biol Psychiatry. 2024 Jun 15;95(12):1072-1080. doi: 10.1016/j.biopsych.2023.11.010. Epub 2023 Nov 18.
2
The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: a cross-sectional multicentered study.沙特阿拉伯多发性硬化症患者中重度抑郁症和广泛性焦虑症的患病率:一项横断面多中心研究。
Front Psychiatry. 2023 Aug 29;14:1195101. doi: 10.3389/fpsyt.2023.1195101. eCollection 2023.
3
Caudate volume and symptoms of apathy in older adults with multiple sclerosis.
老年多发性硬化症患者尾状核体积与淡漠症状的关系。
Mult Scler. 2023 Sep;29(10):1266-1274. doi: 10.1177/13524585231188096. Epub 2023 Aug 1.
4
Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron.复发缓解型多发性硬化所致情绪症状和慢性疲劳综合征与免疫激活及红细胞异常有关。
Brain Sci. 2023 Jul 14;13(7):1073. doi: 10.3390/brainsci13071073.
5
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis.抑郁症状、焦虑和认知障碍:多发性硬化症中的新证据。
Transl Psychiatry. 2023 Jul 19;13(1):264. doi: 10.1038/s41398-023-02555-7.
6
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients.抑郁症对多发性硬化症患者疲劳感和信息处理速度的影响。
BMC Psychol. 2023 Jul 14;11(1):208. doi: 10.1186/s40359-023-01235-x.
7
Improving risk prediction for target subpopulations: Predicting suicidal behaviors among multiple sclerosis patients.提高目标亚人群的风险预测能力:预测多发性硬化症患者的自杀行为。
PLoS One. 2023 Feb 16;18(2):e0277483. doi: 10.1371/journal.pone.0277483. eCollection 2023.
8
Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial.认知康复和正念可减少多发性硬化症患者的认知主诉(REMIND-MS):一项随机对照试验。
Mult Scler Relat Disord. 2023 Mar;71:104529. doi: 10.1016/j.msard.2023.104529. Epub 2023 Jan 20.
9
Relationship of Motor Impairment with Cognitive and Emotional Alterations in Patients with Multiple Sclerosis.多发性硬化症患者运动障碍与认知和情绪改变的关系。
Int J Environ Res Public Health. 2023 Jan 12;20(2):1387. doi: 10.3390/ijerph20021387.
10
Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia.沙特阿拉伯利雅得市成年多发性硬化症患者的抑郁和焦虑患病率。
Neurosciences (Riyadh). 2022 Apr;27(2):71-78. doi: 10.17712/nsj.2022.2.20210101.